ZyVersa Therapeutics (ZVSA) Stock Chart & Stock Price History → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free ZVSA Stock Alerts $4.49 -0.37 (-7.62%) (As of 05/17/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media ZyVersa Therapeutics Stock Price Performance5 Day Performance-15.18%1 Month Performance-23.43%3 Month Performance-23.93%6 Month Performance-84.33%Year-To-Date Performance-50.14%1 Year Performance-96.96% Receive ZVSA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ZyVersa Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad The Freeport SocietyBiden Nomination CANCELED?The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words?I believe I have the terrifying answer right here. ZVSA Stock Chart for Sunday, May, 19, 2024 ZVSA Chart by TradingView ZyVersa Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$4.86$4.50-7.41%$5.08$4.4596,047 shs$3.42 million05/16/2024$4.94$4.86-1.62%$4.99$4.8325,053 shs$3.69 million05/15/2024$5.29$4.94-6.62%$5.34$4.8658,445 shs$3.75 million05/14/2024$5.46$5.29-3.11%$5.46$5.2155,332 shs$4.02 million05/13/2024$5.37$5.46+1.68%$5.52$5.1847,104 shs$4.15 million05/10/2024$5.28$5.37+1.70%$5.44$5.1661,439 shs$4.08 million Get the Latest News and Ratings for ZVSA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ZyVersa Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$5.60$5.28-5.71%$5.64$5.10162,508 shs$4.01 million05/08/2024$6.47$5.60-13.45%$6.58$5.50137,940 shs$4.26 million05/07/2024$6.39$6.47+1.25%$6.69$6.06211,426 shs$4.92 million05/06/2024$5.45$6.39+17.25%$6.55$5.65514,208 shs$4.86 million05/03/2024$5.74$5.45-5.05%$6.00$5.25374,652 shs$4.14 million05/02/2024$5.24$5.74+9.54%$6.08$5.15203,548 shs$3.97 million05/01/2024$5.29$5.24-0.95%$5.90$5.15187,813 shs$3.98 million04/30/2024$5.77$5.29-8.32%$5.59$5.09188,843 shs$4.02 million04/29/2024$4.99$5.77+15.63%$6.70$5.158.04 million shs$4.39 million04/26/2024$6.08$4.99-17.86%$6.20$4.44439,563 shs$37.82 million04/25/2024$6.10$6.08-0.41%$6.30$5.6039,656 shs$4.61 million04/24/2024$5.72$6.10+6.64%$6.20$5.7432,864 shs$4.62 million04/23/2024$5.75$5.72-0.49%$5.85$5.5015,457 shs$4.34 million04/22/2024$5.86$5.75-1.91%$6.04$5.5024,136 shs$4.36 million04/19/2024$6.26$5.86-6.39%$6.40$5.7128,422 shs$4.44 million04/18/2024$5.83$6.26+7.47%$6.42$5.8342,202 shs$4.75 million04/17/2024$5.78$5.83+0.85%$6.00$5.6021,176 shs$4.42 million04/16/2024$6.36$5.78-9.11%$6.30$5.7032,927 shs$4.38 million04/15/2024$7.10$6.36-10.49%$7.30$6.3046,109 shs$4.82 million04/12/2024$7.50$7.10-5.33%$7.60$7.0035,659 shs$5.38 million04/11/2024$7.50$7.50$8.05$7.2037,224 shs$5.69 million04/10/2024$7.18$7.50+4.49%$7.50$7.0320,367 shs$5.69 million04/09/2024$7.33$7.18-2.05%$7.36$7.159,057 shs$5.44 million04/08/2024$7.34$7.33-0.11%$7.66$7.2019,113 shs$5.56 million04/05/2024$7.40$7.34-0.92%$7.46$7.2029,511 shs$5.56 million04/04/2024$7.13$7.40+3.92%$7.86$7.20111,254 shs$5.61 million04/03/2024$7.29$7.13-2.26%$7.50$6.9312,803 shs$5.40 million04/02/2024$7.43$7.29-1.88%$7.47$6.8116,410 shs$5.53 million04/01/2024$7.50$7.43-0.93%$7.65$7.2018,879 shs$5.63 million03/29/2024$7.50$7.50$8.40$7.4087,173 shs$5.69 million03/28/2024$7.78$7.50-3.54%$8.40$7.4086,534 shs$5.69 million03/27/2024$7.49$7.78+3.79%$7.82$7.1640,369 shs$5.89 million03/26/2024$8.00$7.49-6.36%$8.00$7.0944,762 shs$5.68 million03/25/2024$8.16$8.00-1.96%$8.17$7.8032,577 shs$6.06 million[URGENT] DO NOT Touch These AI Stocks! (Ad)Artificial intelligence stocks are carrying the market. One of them, Nvidia, recently became the seventh company ever to hit a $1 trillion market cap. But is this AI rally over?Click here for our #1 AI Stock for 2024 and Beyond03/22/2024$8.20$8.16-0.49%$8.30$7.9023,917 shs$6.19 million03/21/2024$8.42$8.20-2.66%$8.56$8.0037,939 shs$6.22 million03/20/2024$8.11$8.42+3.87%$8.71$7.9031,051 shs$6.39 million03/19/2024$8.49$8.11-4.49%$8.50$7.6064,287 shs$6.15 million03/18/2024$7.81$8.49+8.79%$10.20$8.00705,359 shs$6.44 million03/15/2024$7.99$7.81-2.30%$8.34$7.8142,065 shs$5.92 million03/14/2024$7.81$7.99+2.29%$8.20$7.9038,744 shs$6.06 million03/13/2024$7.89$7.81-1.03%$8.20$7.5036,723 shs$5.92 million03/12/2024$8.66$7.89-8.87%$8.90$7.8047,759 shs$5.98 million03/11/2024$9.49$8.66-8.80%$9.73$8.20105,299 shs$6.56 million03/08/2024$9.55$9.49-0.57%$10.60$9.2081,810 shs$1.18 million03/07/2024$7.69$9.55+24.18%$10.80$7.60344,904 shs$1.18 million03/06/2024$8.60$7.69-10.59%$8.84$7.5070,975 shs$953,000.0003/05/2024$9.60$8.60-10.37%$9.10$8.3092,791 shs$1.07 million03/04/2024$10.40$9.60-7.74%$10.30$9.02108,470 shs$1.19 million03/01/2024$11.00$10.40-5.45%$11.80$10.20134,504 shs$1.29 million02/29/2024$10.00$11.00+10.00%$12.00$9.62391,632 shs$1.36 million02/28/2024$10.90$10.00-8.26%$12.40$9.31542,618 shs$1.24 million02/27/2024$10.80$10.90+0.93%$13.40$10.401.19 million shs$1.35 million02/26/2024$8.01$10.80+34.83%$25.00$10.408.87 million shs$1.34 million02/23/2024$6.20$8.01+29.13%$8.38$5.80715,935 shs$993,000.0002/22/2024$6.10$6.20+1.69%$7.28$6.10178,163 shs$769,000.0002/21/2024$5.97$6.10+2.25%$8.40$5.73392,608 shs$756,000.0002/20/2024$5.90$5.97+1.14%$6.20$5.8026,102 shs$743,000.0002/19/2024$5.90$5.90$6.20$5.8018,490 shs$731,000.00 Related Companies: SEEL Stock Price Chart SNGX Stock Price Chart EVOK Stock Price Chart ENSC Stock Price Chart GOVX Stock Price Chart PTPI Stock Price Chart CYCC Stock Price Chart ALZN Stock Price Chart XCUR Stock Price Chart BCEL Stock Price Chart Receive ZVSA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ZyVersa Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ZVSA) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetryCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMost important medical advance in 100 yearsThe Oxford ClubNext President (Not Trump. Not Biden.)The Freeport SocietyCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceProtect Your Bank Account Before It’s Too LateWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZyVersa Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.